A possible interaction between lithium and rofecoxib [1]

British Journal of Clinical Pharmacology

Volumn 53, Issue 4, 2002, Pages 403-404

  Lundmark, Jöns ^a   Gunnarsson, Tove ^a   Bengtsson, Finn ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CREATININE; CYCLOOXYGENASE 2 INHIBITOR; EDETIC ACID; FUROSEMIDE; LITHIUM; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; SOTALOL; WARFARIN;

AGED; ANTICOAGULANT THERAPY; AORTA VALVE REPLACEMENT; ARTHRALGIA; CASE REPORT; CHRONIC KIDNEY FAILURE; CONFUSION; CORONARY ARTERY BYPASS SURGERY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG SELECTIVITY; DRUG WITHDRAWAL; GAIT DISORDER; GLOMERULUS FILTRATION RATE; HIP DISEASE; HUMAN; KIDNEY FUNCTION; LETTER; MAINTENANCE THERAPY; MALE; MANIC DEPRESSIVE PSYCHOSIS; NEPHROTOXICITY; PRIORITY JOURNAL; SOMNOLENCE; TREMOR;

AGED; CREATININE; DEPRESSION; DRUG INTERACTIONS; HUMANS; LACTONES; LITHIUM; MALE; PAIN; SULFONES;

EID: 0036231829     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2002.01572_1.x     Document Type: Letter

References (5)

1. Lithium nephrotoxicity. A combined glomerular and tubulointerstitial nephrotoxicity
2. Clinical relevance of drug interactions with lithium
3. Effects of nonsteroidal anti-inflammatory drugs on renal function: Focus on cyclooxygenase-2-selective inhibition
4. Are COX-2 selective inhibitors nephrotoxic?
5. Pharmacokinetic effects of rofecoxib therapy on lithium